{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T19:07:36Z","timestamp":1768072056139,"version":"3.49.0"},"reference-count":59,"publisher":"Oncology Nursing Society (ONS)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ONF"],"published-print":{"date-parts":[[2021,5,1]]},"DOI":"10.1188\/21.onf.291-307","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T07:23:20Z","timestamp":1618471400000},"page":"291-307","source":"Crossref","is-referenced-by-count":2,"title":["Frailty in Patients With Hematologic Malignancies and Those Undergoing Transplantation: A Scoping Review"],"prefix":"10.1188","volume":"48","author":[{"given":"Lathika","family":"Mohanraj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lana","family":"Sargent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Swift-Scanlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abel, G.A., & Klepin, H.D. (2018). Frailty and the management of hematologic malignancies. Blood, 131(5), 515\u2013524. https:\/\/doi.org\/10.1182\/blood-2017-09-746420","DOI":"10.1182\/blood-2017-09-746420"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Arora, M., Sun, C.-L., Ness, K.K., Teh, J.B., Wu, J., Francisco, L., . . . Bhatia, S. (2016). Physiologic frailty in nonelderly hematopoietic cell transplantation patients: Results from the bone marrow transplant survivor study. JAMA Oncology, 2(10), 1277\u20131286. https:\/\/doi.org\/10.1001\/jamaoncol.2016.0855","DOI":"10.1001\/jamaoncol.2016.0855"},{"key":"3","unstructured":"Artz, A., & Sorror, M.L. (2021, March 11). Composite Health Assessment Risk Model (CHARM) for older adults (BMT CTN 1704). ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03992352"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Artz, A., Swanson, K., Kocherginsky, M., Godley, L., Kline, J., Nguyen, V., . . . van Besien, K. (2011). Features of frailty are surprisingly common in adults 50 years and older undergoing allogeneic hematopoietic cell transplantation (HCT) in the modern era [Abstract 409]. Biology of Blood and Marrow Transplantation, 17(2, Suppl.), S302. https:\/\/doi.org\/10.1016\/j.bbmt.2010.12.445","DOI":"10.1016\/j.bbmt.2010.12.445"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Buckstein, R., Wells, R.A., Zhu, N., Leitch, H.A., Nevill, T.J., Yee, K.W.L., . . . Alibhai, S.M.H. (2016). Patient-related factors independently impact overall survival in patients with myelodysplastic syndromes: An MDS-CAN prospective study. British Journal of Haematology, 174(1), 88\u2013101. https:\/\/doi.org\/10.1111\/bjh.14033","DOI":"10.1111\/bjh.14033"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Budziszewska, B.K., Pluta, A., Sulek, K., Wierzbowska, A., Robak, T., Giebel, S., . . . Lech-Maranda, E. (2015). Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: A Polish Adult Leukemia Group study. Leukemia and Lymphoma, 56(8), 2331\u20132338. https:\/\/doi.org\/10.3109\/10428194.2014.985672","DOI":"10.3109\/10428194.2014.985672"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Charlson, M.E., Pompei, P., Ales, K.L., & MacKenzie, C.R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"8","doi-asserted-by":"crossref","unstructured":"Chemaitilly, W., & Robison, L.L. (2012). Safety of growth hormone treatment in patients previously treated for cancer. Endocrinology and Metabolism Clinics of North America, 41(4), 785\u2013792. https:\/\/doi.org\/10.1016\/j.ecl.2012.07.002","DOI":"10.1016\/j.ecl.2012.07.002"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Corsetti, M.T., Salvi, F., Perticone, S., Baraldi, A., De Paoli, L., Gatto, S., . . . Levis, A. (2011). Hematologic improvement and response in elderly AML\/RAEB patients treated with valproic acid and low-dose Ara-C. Leukemia Research, 35(8), 991\u2013997. https:\/\/doi.org\/10.1016\/j.leukres.2011.02.021","DOI":"10.1016\/j.leukres.2011.02.021"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Crooks, V., Waller, S., Smith, T., & Hahn, T.J. (1991). The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. Journal of Gerontology, 46(4), M139\u2013M144. https:\/\/doi.org\/10.1093\/geronj\/46.4.M139","DOI":"10.1093\/geronj\/46.4.M139"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Domm, A.-S., Hieke, S., Ihorst, G., Pantic, M., Koch, B., Kleber, M., . . . Engelhardt, M. (2014). Importance and determinants of comorbidities, functional limitations and multiple myeloma (MM)-specific risk factors: Further development of an improved and weighted MM-risk score (Freiburg Comorbidity Index [FCI]). Blood, 124(21), 733. https:\/\/doi.org\/10.1182\/blood.v124.21.733.733","DOI":"10.1182\/blood.V124.21.733.733"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Eissa, H.M., Lu, L., Baassiri, M., Bhakta, N., Ehrhardt, M.J., Triplett, B.M., . . . Ness, K.K. (2017). Chronic disease burden and frailty in survivors of childhood HSCT: A report from the St. Jude Lifetime Cohort Study. Blood Advances, 1(24), 2243\u20132246. https:\/\/doi.org\/10.1182\/bloodadvances.2017010280","DOI":"10.1182\/bloodadvances.2017010280"},{"key":"13","doi-asserted-by":"crossref","unstructured":"El Assar, M., Laosa, O., & Rodr\u00edguez Ma\u00f1as, L. (2019). Diabetes and frailty. Current Opinion in Clinical Nutrition and Metabolic Care, 22(1), 52\u201357. https:\/\/doi.org\/10.1097\/MCO.0000000000000535","DOI":"10.1097\/MCO.0000000000000535"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Engelhardt, M., Dold, S.M., Ihorst, G., Zober, A., M\u00f6ller, M., Reinhardt, H., . . . W\u00e4sch, R. (2016). Geriatric assessment in multiple myeloma patients: Validation of the International Myeloma Working Group (IMWG) score and comparison with other common comorbidity scores. Haematologica, 101(9), 1110\u20131119. https:\/\/doi.org\/10.3324\/haematol.2016.148189","DOI":"10.3324\/haematol.2016.148189"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Engelhardt, M., Domm, A.-S., Dold, S.M., Ihorst, G., Reinhardt, H., Zober, A., . . . W\u00e4sch, R. (2017). A concise revised Myeloma Comorbidity Index as a valid prognostic instrument in a large cohort of 801 multiple myeloma patients. Haematologica, 102(5), 910\u2013921. https:\/\/doi.org\/10.3324\/haematol.2016.162693","DOI":"10.3324\/haematol.2016.162693"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Extermann, M. (2000). Measuring comorbidity in older cancer patients. European Journal of Cancer, 36(4), 453\u2013471.","DOI":"10.1016\/S0959-8049(99)00319-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Extermann, M., & Hurria, A. (2007). Comprehensive geriatric assessment for older patients with cancer. Journal of Clinical Oncology , 25(14), 1824\u20131831. https:\/\/doi.org\/10.1200\/JCO.2007.10.6559","DOI":"10.1200\/JCO.2007.10.6559"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Feinstein, A.R. (1970). The pre-therapeutic classification of co-morbidity in chronic disease. Journal of Chronic Diseases, 23(7), 455\u2013468. https:\/\/doi.org\/10.1016\/0021-9681(70)90054-8","DOI":"10.1016\/0021-9681(70)90054-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Ferrat, E., Paillaud, E., Caillet, P., Laurent, M., Tournigand, C., Lagrange, J.-L., . . . Bastuji-Garin, S. (2017). Performance of four frailty classifications in older patients with cancer: Prospective elderly cancer patients cohort study. Journal of Clinical Oncology, 35(7), 766\u2013777. https:\/\/doi.org\/10.1200\/JCO.2016.69.3143","DOI":"10.1200\/JCO.2016.69.3143"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Fried, L.P., Tangen, C.M., Walston, J., Newman, A.B., Hirsch, C., Gottdiener, J., . . . McBurnie, M.A. (2001). Frailty in older adults: Evidence for a phenotype. Journals of Gerontology Series A, 56(3), M146\u2013M157. https:\/\/doi.org\/10.1093\/gerona\/56.3.m146","DOI":"10.1093\/gerona\/56.3.M146"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Hamaker, M.E., Jonker, J.M., de Rooij, S.E., Vos, A.G., Smorenburg, C.H., & van Munster, B.C. (2012). Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: A systematic review. Lancet Oncology, 13(10), E437\u2013E444. https:\/\/doi.org\/10.1016\/S1470-2045(12)70259-0","DOI":"10.1016\/S1470-2045(12)70259-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Handforth, C., Clegg, A., Young, C., Simpkins, S., Seymour, M.T., Selby, P.J., & Young, J. (2015). The prevalence and outcomes of frailty in older cancer patients: A systematic review. Annals of Oncology, 26(6), 1091\u20131101. https:\/\/doi.org\/10.1093\/annonc\/mdu540","DOI":"10.1093\/annonc\/mdu540"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Hegde, A., & Murthy, H.S. (2018). Frailty: The missing piece of the pre-hematopoietic cell transplantation assessment? Bone Marrow Transplantation, 53(1), 3\u201310. https:\/\/doi.org\/10.1038\/bmt.2017.192","DOI":"10.1038\/bmt.2017.192"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Holmes, H.M., Des Bordes, J.K.A., Kebriaei, P., Yennu, S., Champlin, R.E., Giralt, S., & Mohile, S.G. (2014). Optimal screening for geriatric assessment in older allogeneic hematopoietic cell transplantation candidates. Journal of Geriatric Oncology, 5(4), 422\u2013430. https:\/\/doi.org\/10.1016\/j.jgo.2014.04.004","DOI":"10.1016\/j.jgo.2014.04.004"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Hshieh, T.T., Jung, W.F., Grande, L.J., Chen, J., Stone, R.M., Soiffer, R.J., . . . Abel, G.A. (2018). Prevalence of cognitive impairment and association with survival among older patients with hematologic cancers. JAMA Oncology, 4(5), 686\u2013693. https:\/\/doi.org\/10.1001\/jamaoncol.2017.5674","DOI":"10.1001\/jamaoncol.2017.5674"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Marchesi, F., Cenfra, N., Altomare, L., Dessanti, M.L., Mecarocci, S., Cerchiara, E., . . . Cimino, G. (2013). A retrospective study on 73 elderly patients (\u226575years) with aggressive B-cell non Hodgkin lymphoma: Clinical significance of treatment intensity and comprehensive geriatric assessment. Journal of Geriatric Oncology, 4(3), 242\u2013248. https:\/\/doi.org\/10.1016\/j.jgo.2013.04.003","DOI":"10.1016\/j.jgo.2013.04.003"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Mellqvist, U.-H. (2015). New prognostic tools for myeloma. Blood, 125(13), 2014\u20132015. https:\/\/doi.org\/10.1182\/blood-2015-02-626408","DOI":"10.1182\/blood-2015-02-626408"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Milani, P., Rajkumar, S.V., Merlini, G., Kumar, S., Gertz, M.A., Palladini, G., . . . Dispenzieri, A. (2016). N-terminal fragment of the type-B natriuretic peptide (NT-proBNP) contributes to a simple new frailty score in patients with newly diagnosed multiple myeloma. American Journal of Hematology, 91(11), 1129\u20131134. https:\/\/doi.org\/10.1002\/ajh.24532","DOI":"10.1002\/ajh.24532"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Mohile, S.G., & Magnuson, A. (2013). Comprehensive geriatric assessment in oncology. Interdisciplinary Topics in Gerontology, 38, 85\u2013103. https:\/\/doi.org\/10.1159\/000343608","DOI":"10.1159\/000343608"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Molica, S., Giannarelli, D., Levato, L., Mirabelli, R., Levato, D., Lentini, M., & Piro, E. (2019). A simple score based on geriatric assessment predicts survival in elderly newly diagnosed chronic lymphocytic leukemia patients. Leukemia and Lymphoma, 60(3), 845\u2013847. https:\/\/doi.org\/10.1080\/10428194.2018.1508674","DOI":"10.1080\/10428194.2018.1508674"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Morgan, B., & Tarbi, E. (2016). The role of the advanced practice nurse in geriatric oncology care. Seminars in Oncology Nursing, 32(1), 33\u201343. https:\/\/doi.org\/10.1016\/j.soncn.2015.11.005","DOI":"10.1016\/j.soncn.2015.11.005"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Morley, J.E., Vellas, B., Abellan van Kan, G., Anker, S.D., Bauer, J.M., Bernabei, R., . . . Walston, J. (2013). Frailty consensus: A call to action. Journal of the American Medical Directors Association, 14(6), 392\u2013397. https:\/\/doi.org\/10.1016\/j.jamda.2013.03.022","DOI":"10.1016\/j.jamda.2013.03.022"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Morrison, V.A., Hamlin, P., Soubeyran, P., Stauder, R., Wadhwa, P., Aapro, M., & Lichtman, S. (2015). Diffuse large B-cell lymphoma in the elderly: Impact of prognosis, comorbidities, geriatric assessment, and supportive care on clinical practice. An International Society of Geriatric Oncology (SIOG) expert position paper. Journal of Geriatric Oncology, 6(2), 141\u2013152. https:\/\/doi.org\/10.1016\/j.jgo.2014.11.004","DOI":"10.1016\/j.jgo.2014.11.004"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Muffly, L.S., Boulukos, M., Swanson, K., Kocherginsky, M., del Cerro, P., Schroeder, L., . . . Artz, A.S. (2013). Pilot study of comprehensive geriatric assessment (CGA) in allogeneic transplant: CGA captures a high prevalence of vulnerabilities in older transplant recipients. Biology of Blood and Marrow Transplantation, 19(3), 429\u2013434. https:\/\/doi.org\/10.1016\/j.bbmt.2012.11.006","DOI":"10.1016\/j.bbmt.2012.11.006"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Muffly, L.S., Kocherginsky, M., Stock, W., Chu, Q., Bishop, M.R., Godley, L.A., . . . Artz, A.S. (2014). Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients. Haematologica, 99(8), 1373\u20131379. https:\/\/doi.org\/10.3324\/haematol.2014.103655","DOI":"10.3324\/haematol.2014.103655"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Ness, K.K., Krull, K.R., Jones, K.E., Mulrooney, D.A., Armstrong, G.T., Green, D.M., . . . Hudson, M.M. (2013). Physiologic frailty as a sign of accelerated aging among adult survivors of childhood cancer: A report from the St Jude Lifetime Cohort Study. Journal of Clinical Oncology, 31(36), 4496\u20134503. https:\/\/doi.org\/10.1200\/JCO.2013.52.2268","DOI":"10.1200\/JCO.2013.52.2268"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Offidani, M., Corvatta, L., Polloni, C., Centurioni, R., Visani, G., Brunori, M., . . . Leoni, P. (2012). Assessment of vulnerability measures and their effect on survival in a real-life population of multiple myeloma patients registered at Marche Region Multiple Myeloma Registry. Clinical Lymphoma, Myeloma and Leukemia, 12(6), 423\u2013432. https:\/\/doi.org\/10.1016\/j.clml.2012.06.008","DOI":"10.1016\/j.clml.2012.06.008"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Okuyama, T., Sugano, K., Iida, S., Ishida, T., Kusumoto, S., & Akechi, T. (2015). Screening performance for frailty among older patients with cancer: A cross-sectional observational study of two approaches. Journal of the National Comprehensive Cancer Network, 13(12), 1525\u20131531. https:\/\/doi.org\/10.6004\/jnccn.2015.0180","DOI":"10.6004\/jnccn.2015.0180"},{"key":"39","doi-asserted-by":"crossref","unstructured":"Palumbo, A., Bringhen, S., Mateos, M.-V., Larocca, A., Facon, T., Kumar, S.K., . . . Rajkumar, S.V. (2015). Geriatric assessment predicts survival and toxicities in elderly myeloma patients: An International Myeloma Working Group report. Blood, 125(13), 2068\u20132074. https:\/\/doi.org\/10.1182\/blood-2014-12-615187","DOI":"10.1182\/blood-2014-12-615187"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Park, S., Hong, J., Hwang, I., Ahn, J.-Y., Cho, E.Y., Park, J., . . . Lee, J.H. (2015). Comprehensive geriatric assessment in elderly patients with newly diagnosed aggressive non-Hodgkin lymphoma treated with multi-agent chemotherapy. Journal of Geriatric Oncology, 6(6), 470\u2013478. https:\/\/doi.org\/10.1016\/j.jgo.2015.10.183","DOI":"10.1016\/j.jgo.2015.10.183"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Pel-Littel, R.E., Schuurmans, M.J., Emmelot-Vonk, M.H., & Verhaar, H.J.J. (2009). Frailty: Defining and measuring of a concept. Journal of Nutrition, Health and Aging, 13(4), 390\u2013394. https:\/\/doi.org\/10.1007\/s12603-009-0051-8","DOI":"10.1007\/s12603-009-0051-8"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Perna, S., Francis, M.D.A., Bologna, C., Moncaglieri, F., Riva, A., Morazzoni, P., . . . Rondanelli, M. (2017). Performance of Edmonton Frail Scale on frailty assessment: Its association with multi-dimensional geriatric conditions assessed with specific screening tools. BMC Geriatrics, 17, 2. https:\/\/doi.org\/10.1186\/s12877-016-0382-3","DOI":"10.1186\/s12877-016-0382-3"},{"key":"43","unstructured":"Phelan, R., Arora, M., & Chen, M. (2020). Current use and outcome of hematopoietic stem cell transplantation. Center for International Blood and Marrow Transplant Research. https:\/\/www.cibmtr.org\/ReferenceCenter\/SlidesReports\/SummarySlides\/pages..."},{"key":"44","doi-asserted-by":"crossref","unstructured":"Pidala, J., Craig, B.M., Lee, S.J., Majhail, N., Quinn, G., & Anasetti, C. (2013). Practice variation in physician referral for allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation, 48(1), 63\u201367. https:\/\/doi.org\/10.1038\/bmt.2012.95","DOI":"10.1038\/bmt.2012.95"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Rosko, A., Hofmeister, C., Benson, D., Efebera, Y., Huang, Y., Gillahan, J., . . . Burd, C.E. (2015). Autologous hematopoietic stem cell transplant induces the molecular aging of T-cells in multiple myeloma. Bone Marrow Transplantation, 50(10), 1379\u20131381. https:\/\/doi.org\/10.1038\/bmt.2015.143","DOI":"10.1038\/bmt.2015.143"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Rosko, A.E., Huang, Y., Benson, D.M., Efebera, Y.A., Hofmeister, C., Jaglowski, S., . . . Burd, C.E. (2019). Use of a comprehensive frailty assessment to predict morbidity in patients with multiple myeloma undergoing transplant. Journal of Geriatric Oncology, 10(3), 479\u2013485. https:\/\/doi.org\/10.1016\/j.jgo.2018.05.015","DOI":"10.1016\/j.jgo.2018.05.015"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Sakatoku, K., Takeoka, Y., Miura, A., Araki, T., Fujitani, Y., Yamamura, R., . . . Hino, M. (2019). Combination of frailty status and comorbidity score improves the stratification of survival in patients with myelodysplastic syndrome owing to good predictive capability for infection-related mortality. Clinical Lymphoma, Myeloma and Leukemia, 19(12), 799\u2013805. https:\/\/doi.org\/10.1016\/j.clml.2019.09.610","DOI":"10.1016\/j.clml.2019.09.610"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Saliba, D., Elliott, M., Rubenstein, L.Z., Solomon, D.H., Young, R.T., Kamberg, C.J., . . . Wenger, N.S. (2001). The Vulnerable Elders Survey: A tool for identifying vulnerable older people in the community. Journal of the American Geriatrics Society, 49(12), 1691\u20131699. https:\/\/doi.org\/10.1046\/j.1532-5415.2001.49281.x","DOI":"10.1046\/j.1532-5415.2001.49281.x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"Searle, S.D., & Rockwood, K. (2015). Frailty and the risk of cognitive impairment. Alzheimer\u2019s Research and Therapy, 7(1), 54. https:\/\/doi.org\/10.1186\/s13195-015-0140-3","DOI":"10.1186\/s13195-015-0140-3"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Song, X., Mitnitski, A., & Rockwood, K. (2014). Age-related deficit accumulation and the risk of late-life dementia. Alzheimer\u2019s Research and Therapy, 6(5), 54. https:\/\/doi.org\/10.1186\/s13195-014-0054-5","DOI":"10.1186\/s13195-014-0054-5"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Sorror, M.L., Maris, M.B., Storb, R., Baron, F., Sandmaier, B.M., Maloney, D.G., & Storer, B. (2005). Hematopoietic Cell Transplantation (HCT)-Specific Comorbidity Index: A new tool for risk assessment before allogeneic HCT. Blood, 106(8), 2912\u20132919. https:\/\/doi.org\/10.1182\/blood-2005-05-2004","DOI":"10.1182\/blood-2005-05-2004"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Spina, M., Balzarotti, M., Uziel, L., Ferreri, A.J.M., Fratino, L., Magagnoli, M., . . . Tirelli, U. (2012). Modulated chemotherapy according to modified comprehensive geriatric assessment in 100 consecutive elderly patients with diffuse large B-cell lymphoma. Oncologist, 17(6), 838\u2013846. https:\/\/doi.org\/10.1634\/theoncologist.2011-0417","DOI":"10.1634\/theoncologist.2011-0417"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Tay, J., Daly, A., Jamani, K., Labelle, L., Savoie, L., Stewart, D., . . . Beattie, S. (2019). Patient eligibility for hematopoietic stem cell transplantation: A review of patient-associated variables. Bone Marrow Transplantation, 54(3), 368\u2013382.","DOI":"10.1038\/s41409-018-0265-7"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Tricco, A.C., Lillie, E., Zarin, W., O\u2019Brien, K.K., Colquhoun, H., Levac, D., . . . Straus, S.E. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467\u2013473. https:\/\/doi.org\/10.7326\/M18-0850","DOI":"10.7326\/M18-0850"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Velghe, A., De Buyser, S., Noens, L., Demuynck, R., & Petrovic, M. (2016). Hand grip strength as a screening tool for frailty in older patients with haematological malignancies. Acta Clinica Belgica, 71(4), 227\u2013230. https:\/\/doi.org\/10.1080\/17843286.2016.1162381","DOI":"10.1080\/17843286.2016.1162381"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Walston, J., Buta, B., & Xue, Q.-L. (2018). Frailty screening and interventions: Considerations for clinical practice. Clinics in Geriatric Medicine, 34(1), 25\u201338. https:\/\/doi.org\/10.1016\/j.cger.2017.09.004","DOI":"10.1016\/j.cger.2017.09.004"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Wilson, C.L., Chemaitilly, W., Jones, K.E., Kaste, S.C., Srivastava, D.K., Ojha, R.P., . . . Ness, K.K. (2016). Modifiable factors associated with aging phenotypes among adult survivors of childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 34(21), 2509\u20132515. https:\/\/doi.org\/10.1200\/JCO.2015.64.9525","DOI":"10.1200\/JCO.2015.64.9525"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Wiskemann, J., Dreger, P., Schwerdtfeger, R., Bondong, A., Huber, G., Kleindienst, N., . . . Bohus, M. (2011). Effects of a partly self-administered exercise program before, during, and after allogeneic stem cell transplantation. Blood, 117(9), 2604\u20132613. https:\/\/doi.org\/10.1182\/blood-2010-09-306308","DOI":"10.1182\/blood-2010-09-306308"},{"key":"59","unstructured":"Zhong, Y.-P., Zhang, Y.-Z., Liao, A.-J., Li, S.-X., Tian, C., & Lu, J. (2017). Geriatric assessment to predict survival and risk of serious adverse events in elderly newly diagnosed multiple myeloma patients: A multicenter study in China. Chinese Medical Journal, 130(2), 130\u2013134."}],"container-title":["Oncology Nursing Forum"],"original-title":[],"link":[{"URL":"http:\/\/onf.ons.org\/onf\/48\/3\/frailty-patients-hematologic-malignancies-and-those-undergoing-transplantation-scoping","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:49:43Z","timestamp":1763754583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/onf\/48\/3\/frailty-patients-hematologic-malignancies-and-those-undergoing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5,1]]}},"URL":"https:\/\/doi.org\/10.1188\/21.onf.291-307","relation":{},"ISSN":["0190-535X","1538-0688"],"issn-type":[{"value":"0190-535X","type":"print"},{"value":"1538-0688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]}}}